First evidence of AXL expression on circulating tumor cells in metastatic breast cancer patients: A proof‐of‐concept study

First evidence of AXL expression on circulating tumor cells in metastatic breast cancer patients: A proof‐of‐concept study

Abstract Background For several years, the AXL tyrosine kinase receptor, a member of the Tyro3‐Axl‐Mer (TAM) family, has been considered a new strategic target in oncology. AXL overexpression is common in solid tumors and is associated with poor prognosis. In this context, the detection of a subset...

Full description

Bibliographic Details
Main Authors: Thomas Bardol, Zahra Eslami‐S, Doryan Masmoudi, Marie Alexandre, Marie Duboys de Labarre, Angélique Bobrie, Véronique D'Hondt, Séverine Guiu, Keerthi Kurma, Laure Cayrefourcq, William Jacot, Catherine Alix‐Panabières
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Cancer Medicine
Subjects:
AXL
circulating biomarker
circulating tumor cells
liquid biopsy
metastatic breast cancer
Online Access:https://doi.org/10.1002/cam4.6843

Internet

https://doi.org/10.1002/cam4.6843

Similar Items